FiercePharma17h
BioNTech reports surprising COVID vaccine sales in Q3 but tempers expectations for annual sales
Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2 ...
BioSpace16h
BioNTech Handily Beats Q3 Expectations, Trims Full-Year Revenue Guidance
Driven by the early approval of its updated COVID-19 vaccine, BioNTech far exceeded analysts’ expectations in the third ...
BioNTech Beats Expectations, Gives Update on Cancer Drugs
BioNTech SE reported a surprise profit in the third quarter, helped by solid sales of its variant-adapted Covid-19 vaccines.Mainz, Germany-based BioNTech posted earnings of €0.81 ($0.88) per diluted ...
Cautious Outlook on BioNTech SE: Strong Q3 Performance Overshadowed by Uncertain Future in Vaccine Sales and Oncology Pipeline
BioNTech SE (BNTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yaron Werber ...
BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
BioNTech's Q3 revenue surged to €1.244 billion, reflecting early COVID-19 vaccine approvals. Net profit rose to €198.1 million, and full-year guidance adjusted downward.
Rand Paul hits 'Biden/Harris CDC' over COVID-19 vaccine guidance for 6-month-olds
Sen. Rand Paul pointed to CDC guidance on child COVID-19 vaccinations, suggesting that people are "hesitant to believe" the ...
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
Presented clinical data for multiple assets across modalities, including bispecific antibody candidate BNT327/PM8002 and mRNA cancer vaccine ...
Fact Check: WHO didn't ‘admit’ monkeypox is a side effect of Pfizer’s COVID vaccine
Unverified data about events after vaccinations is not evidence that the vaccine caused the event, as suggested in social ...
Fact Check: Q&A on the 2024-2025 COVID-19 Vaccines
Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...
Singapore Business Review on MSN8d
Gov't authorizes COVID-19 vaccine from Pfizer and BioNTech
The Health Sciences Authority has authorised Pfizer and BioNTech SE ’s updated COVID-19 vaccine tailored to the Omicron JN.1 ...
Business Insider1d
BioNTech’s Q3 2024: Strong Revenue and Oncology Progress
BioNTech SE (BNTX) has released an update. BioNTech SE reported a strong third quarter in 2024, with revenues reaching €1.2 billion, largely driven by the successful launch of its variant-adapted ...
Florida’s 2024-2025 COVID-19 Vaccine Guidance Misunderstands, Distorts Existing Science
1-lineage omicron variants of the coronavirus, or SARS-CoV-2. The options include the mRNA vaccines from Pfizer/BioNTech ...